Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2003 Apr;40(4):268–277. doi: 10.1136/jmg.40.4.268

Chromosome 2 (2p16) abnormalities in Carney complex tumours

L Matyakhina 1, S Pack 1, L Kirschner 1, E Pak 1, P Mannan 1, J Jaikumar 1, S Taymans 1, F Sandrini 1, J Carney 1, C Stratakis 1
PMCID: PMC1735422  PMID: 12676898

Abstract

Carney complex (CNC) is an autosomal dominant multiple endocrine neoplasia and lentiginosis syndrome characterised by spotty skin pigmentation, cardiac, skin, and breast myxomas, and a variety of endocrine and other tumours. The disease is genetically heterogeneous; two loci have been mapped to chromosomes 17q22–24 (the CNC1 locus) and 2p16 (CNC2). Mutations in the PRKAR1A tumour suppressor gene were recently found in CNC1 mapping kindreds, while the CNC2 and perhaps other genes remain unidentified. Analysis of tumour chromosome rearrangements is a useful tool for uncovering genes with a role in tumorigenesis and/or tumour progression. CGH analysis showed a low level 2p amplification recurrently in four of eight CNC tumours; one tumour showed specific amplification of the 2p16-p23 region only. To define more precisely the 2p amplicon in these and other tumours, we completed the genomic mapping of the CNC2 region, and analysed 46 tumour samples from CNC patients with and without PRKAR1A mutations by fluorescence in situ hybridisation (FISH) using bacterial artificial chromosomes (BACs). Consistent cytogenetic changes of the region were detected in 40 (87%) of the samples analysed. Twenty-four samples (60%) showed amplification of the region represented as homogeneously stained regions (HSRs). The size of the amplicon varied from case to case, and frequently from cell to cell in the same tumour. Three tumours (8%) showed both amplification and deletion of the region in their cells. Thirteen tumours (32%) showed deletions only. These molecular cytogenetic changes included the region that is covered by BACs 400-P-14 and 514-O-11 and, in the genetic map, corresponds to an area flanked by polymorphic markers D2S2251 and D2S2292; other BACs on the centromeric and telomeric end of this region were included in varying degrees. We conclude that cytogenetic changes of the 2p16 chromosomal region that harbours the CNC2 locus are frequently observed in tumours from CNC patients, including those with germline, inactivating PRKAR1A mutations. These changes are mostly amplifications of the 2p16 region, that overlap with a previously identified amplicon in sporadic thyroid cancer, and an area often deleted in sporadic adrenal tumours. Both thyroid and adrenal tumours constitute part of CNC indicating that the responsible gene(s) in this area may indeed be involved in both inherited and sporadic endocrine tumour pathogenesis and/or progression.

Full Text

The Full Text of this article is available as a PDF (347.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amler L. C., Schwab M. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Oncogene. 1992 Apr;7(4):807–809. [PubMed] [Google Scholar]
  2. Auer R. L., Jones C., Mullenbach R. A., Syndercombe-Court D., Milligan D. W., Fegan C. D., Cotter F. E. Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood. 2001 Jan 15;97(2):509–515. doi: 10.1182/blood.v97.2.509. [DOI] [PubMed] [Google Scholar]
  3. Bettio D., Giardino D., Rizzi N., Riva P., Volpi L., Barantani E., Tagliaferri A., Larizza L. Isochromosome 15q of maternal origin in a Prader-Willi patient with pituitary adenoma. Acta Genet Med Gemellol (Roma) 1996;45(1-2):213–216. doi: 10.1017/s000156600000132x. [DOI] [PubMed] [Google Scholar]
  4. Carney J. A., Gordon H., Carpenter P. C., Shenoy B. V., Go V. L. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985 Jul;64(4):270–283. doi: 10.1097/00005792-198507000-00007. [DOI] [PubMed] [Google Scholar]
  5. Carney J. A., Hruska L. S., Beauchamp G. D., Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc. 1986 Mar;61(3):165–172. doi: 10.1016/s0025-6196(12)61843-6. [DOI] [PubMed] [Google Scholar]
  6. Casey M., Mah C., Merliss A. D., Kirschner L. S., Taymans S. E., Denio A. E., Korf B., Irvine A. D., Hughes A., Carney J. A. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation. 1998 Dec 8;98(23):2560–2566. doi: 10.1161/01.cir.98.23.2560. [DOI] [PubMed] [Google Scholar]
  7. Chen X., Knauf J. A., Gonsky R., Wang M., Lai E. H., Chissoe S., Fagin J. A., Korenberg J. R. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet. 1998 Aug;63(2):625–637. doi: 10.1086/301973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coquelle A., Pipiras E., Toledo F., Buttin G., Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell. 1997 Apr 18;89(2):215–225. doi: 10.1016/s0092-8674(00)80201-9. [DOI] [PubMed] [Google Scholar]
  9. Couch F. J., Wang X. Y., Wu G. J., Qian J., Jenkins R. B., James C. D. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res. 1999 Apr 1;59(7):1408–1411. [PubMed] [Google Scholar]
  10. Courjal F., Cuny M., Simony-Lafontaine J., Louason G., Speiser P., Zeillinger R., Rodriguez C., Theillet C. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 1997 Oct 1;57(19):4360–4367. [PubMed] [Google Scholar]
  11. Dewald G. W., Dahl R. J., Spurbeck J. L., Carney J. A., Gordon H. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc. 1987 Jul;62(7):558–567. doi: 10.1016/s0025-6196(12)62293-9. [DOI] [PubMed] [Google Scholar]
  12. Figueiredo B. C., Stratakis C. A., Sandrini R., DeLacerda L., Pianovsky M. A., Giatzakis C., Young H. M., Haddad B. R. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab. 1999 Mar;84(3):1116–1121. doi: 10.1210/jcem.84.3.5526. [DOI] [PubMed] [Google Scholar]
  13. George D. L., Scott A. F., de Martinville B., Francke U. Amplified DNA in Y1 mouse adrenal tumor cells: isolation of cDNAs complementary to an amplified c-Ki-ras gene and localization of homologous sequences to mouse chromosome 6. Nucleic Acids Res. 1984 Mar 26;12(6):2731–2743. doi: 10.1093/nar/12.6.2731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gisselsson David, Pålsson Eva, Höglund Mattias, Domanski Henryk, Mertens Fredrik, Pandis Nikos, Sciot Raf, Dal Cin Paola, Bridge Julia A., Mandahl Nils. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer. 2002 Feb;33(2):133–140. doi: 10.1002/gcc.1219. [DOI] [PubMed] [Google Scholar]
  15. Gordon K. B., Thompson C. T., Char D. H., O'Brien J. M., Kroll S., Ghazvini S., Gray J. W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res. 1994 Sep 1;54(17):4764–4768. [PubMed] [Google Scholar]
  16. Hecht F., Ramesh K. H., Lockwood D. H. A guide to fragile sites on human chromosomes. Cancer Genet Cytogenet. 1990 Jan;44(1):37–45. doi: 10.1016/0165-4608(90)90195-g. [DOI] [PubMed] [Google Scholar]
  17. Hemminki A., Tomlinson I., Markie D., Järvinen H., Sistonen P., Björkqvist A. M., Knuutila S., Salovaara R., Bodmer W., Shibata D. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet. 1997 Jan;15(1):87–90. doi: 10.1038/ng0197-87. [DOI] [PubMed] [Google Scholar]
  18. Houldsworth J., Chaganti R. S. Comparative genomic hybridization: an overview. Am J Pathol. 1994 Dec;145(6):1253–1260. [PMC free article] [PubMed] [Google Scholar]
  19. Huang S. C., Koch C. A., Vortmeyer A. O., Pack S. D., Lichtenauer U. D., Mannan P., Lubensky I. A., Chrousos G. P., Gagel R. F., Pacak K. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res. 2000 Nov 15;60(22):6223–6226. [PubMed] [Google Scholar]
  20. Jin Y. T., Myers J., Tsai S. T., Goepfert H., Batsakis J. G., el-Naggar A. K. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol. 1999 May;35(3):251–256. doi: 10.1016/s1368-8375(98)00112-2. [DOI] [PubMed] [Google Scholar]
  21. Kallioniemi A., Kallioniemi O. P., Sudar D., Rutovitz D., Gray J. W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992 Oct 30;258(5083):818–821. doi: 10.1126/science.1359641. [DOI] [PubMed] [Google Scholar]
  22. Kirschner L. S., Carney J. A., Pack S. D., Taymans S. E., Giatzakis C., Cho Y. S., Cho-Chung Y. S., Stratakis C. A. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000 Sep;26(1):89–92. doi: 10.1038/79238. [DOI] [PubMed] [Google Scholar]
  23. Kirschner L. S., Sandrini F., Monbo J., Lin J. P., Carney J. A., Stratakis C. A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet. 2000 Dec 12;9(20):3037–3046. doi: 10.1093/hmg/9.20.3037. [DOI] [PubMed] [Google Scholar]
  24. Kirschner L. S., Stratakis C. A. Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns. Biotechniques. 1999 Jul;27(1):72–74. [PubMed] [Google Scholar]
  25. Kirschner L. S., Stratakis C. A. Structure of the human ubiquitin fusion gene Uba80 (RPS27a) and one of its pseudogenes. Biochem Biophys Res Commun. 2000 Apr 21;270(3):1106–1110. doi: 10.1006/bbrc.2000.2568. [DOI] [PubMed] [Google Scholar]
  26. Kirschner L. S., Taymans S. E., Pack S., Pak E., Pike B. L., Chandrasekharappa S. C., Zhuang Z., Stratakis C. A. Genomic mapping of chromosomal region 2p15-p21 (D2S378-D2S391): integration of Genemap'98 within a framework of yeast and bacterial artificial chromosomes. Genomics. 1999 Nov 15;62(1):21–33. doi: 10.1006/geno.1999.5957. [DOI] [PubMed] [Google Scholar]
  27. Muleris M., Almeida A., Gerbault-Seureau M., Malfoy B., Dutrillaux B. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes Chromosomes Cancer. 1995 Nov;14(3):155–163. doi: 10.1002/gcc.2870140302. [DOI] [PubMed] [Google Scholar]
  28. O'Neill S., Ekstrom L., Lastowska M., Roberts P., Brodeur G. M., Kees U. R., Schwab M., Bown N. MYCN amplification and 17q in neuroblastoma: evidence for structural association. Genes Chromosomes Cancer. 2001 Jan;30(1):87–90. [PubMed] [Google Scholar]
  29. Ohta M., Inoue H., Cotticelli M. G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996 Feb 23;84(4):587–597. doi: 10.1016/s0092-8674(00)81034-x. [DOI] [PubMed] [Google Scholar]
  30. Pack S. D., Karkera J. D., Zhuang Z., Pak E. D., Balan K. V., Hwu P., Park W. S., Pham T., Ault D. O., Glaser M. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer. 1999 Jun;25(2):160–168. doi: 10.1002/(sici)1098-2264(199906)25:2<160::aid-gcc12>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  31. Pack S. D., Zbar B., Pak E., Ault D. O., Humphrey J. S., Pham T., Hurley K., Weil R. J., Park W. S., Kuzmin I. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res. 1999 Nov 1;59(21):5560–5564. [PubMed] [Google Scholar]
  32. Press M. F., Bernstein L., Thomas P. A., Meisner L. F., Zhou J. Y., Ma Y., Hung G., Robinson R. A., Harris C., El-Naggar A. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997 Aug;15(8):2894–2904. doi: 10.1200/JCO.1997.15.8.2894. [DOI] [PubMed] [Google Scholar]
  33. Richards R. I. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet. 2001 Jun;17(6):339–345. doi: 10.1016/s0168-9525(01)02303-4. [DOI] [PubMed] [Google Scholar]
  34. Richkind K. E., Wason D., Vidaillet H. J. Cardiac myxoma characterized by clonal telomeric association. Genes Chromosomes Cancer. 1994 Jan;9(1):68–71. doi: 10.1002/gcc.2870090112. [DOI] [PubMed] [Google Scholar]
  35. Shuster M. I., Han L., Le Beau M. M., Davis E., Sawicki M., Lese C. M., Park N. H., Colicelli J., Gollin S. M. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer. 2000 Jun;28(2):153–163. [PubMed] [Google Scholar]
  36. Simonic I., Gericke G. S. The enigma of common fragile sites. Hum Genet. 1996 Apr;97(4):524–531. doi: 10.1007/BF02267080. [DOI] [PubMed] [Google Scholar]
  37. Sozzi G., Veronese M. L., Negrini M., Baffa R., Cotticelli M. G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell. 1996 Apr 5;85(1):17–26. doi: 10.1016/s0092-8674(00)81078-8. [DOI] [PubMed] [Google Scholar]
  38. Steinarsdóttir M., Pétursdóttir I., Snorradóttir S., Eyfjörd J. E., Ogmundsdóttir H. M. Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer. 1995 Aug;13(4):239–248. doi: 10.1002/gcc.2870130403. [DOI] [PubMed] [Google Scholar]
  39. Stratakis C. A., Carney J. A., Lin J. P., Papanicolaou D. A., Karl M., Kastner D. L., Pras E., Chrousos G. P. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 1996 Feb 1;97(3):699–705. doi: 10.1172/JCI118467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stratakis C. A., Jenkins R. B., Pras E., Mitsiadis C. S., Raff S. B., Stalboerger P. G., Tsigos C., Carney J. A., Chrousos G. P. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J Clin Endocrinol Metab. 1996 Oct;81(10):3607–3614. doi: 10.1210/jcem.81.10.8855810. [DOI] [PubMed] [Google Scholar]
  41. Stratakis C. A., Kirschner L. S., Carney J. A. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001 Sep;86(9):4041–4046. doi: 10.1210/jcem.86.9.7903. [DOI] [PubMed] [Google Scholar]
  42. Stratakis C. A., Taymans S. E. Structure of the gene coding for calcineurin B (PPP3R1) and mapping to D2S358-D2S1778 (chromosomal region 2p15). DNA Seq. 1998;9(4):227–230. doi: 10.3109/10425179809105209. [DOI] [PubMed] [Google Scholar]
  43. Tarttelin E. E., Kirschner L. S., Bellingham J., Baffi J., Taymans S. E., Gregory-Evans K., Csaky K., Stratakis C. A., Gregory-Evans C. Y. Cloning and characterization of a novel orphan G-protein-coupled receptor localized to human chromosome 2p16. Biochem Biophys Res Commun. 1999 Jun 24;260(1):174–180. doi: 10.1006/bbrc.1999.0753. [DOI] [PubMed] [Google Scholar]
  44. Taymans S. E., Kirschner L. S., Giatzakis C., Stratakis C. A. Radiation hybrid mapping of chromosomal region 2p15-p16: integration of expressed and polymorphic sequences maps at the Carney complex (CNC) and Doyne honeycomb retinal dystrophy (DHRD) loci. Genomics. 1999 Mar 15;56(3):344–349. doi: 10.1006/geno.1998.5720. [DOI] [PubMed] [Google Scholar]
  45. Tibiletti M. G., Bernasconi B., Furlan D., Riva C., Trubia M., Buraggi G., Franchi M., Bolis P., Mariani A., Frigerio L. Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res. 1996 Oct 1;56(19):4493–4498. [PubMed] [Google Scholar]
  46. Tsuda H., Akiyama F., Terasaki H., Hasegawa T., Kurosumi M., Shimadzu M., Yamamori S., Sakamoto G. Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression. Cancer. 2001 Dec 15;92(12):2965–2974. doi: 10.1002/1097-0142(20011215)92:12<2965::aid-cncr10156>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  47. Yunis J. J., Soreng A. L. Constitutive fragile sites and cancer. Science. 1984 Dec 7;226(4679):1199–1204. doi: 10.1126/science.6239375. [DOI] [PubMed] [Google Scholar]
  48. Zhuang Z., Park W. S., Pack S., Schmidt L., Vortmeyer A. O., Pak E., Pham T., Weil R. J., Candidus S., Lubensky I. A. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet. 1998 Sep;20(1):66–69. doi: 10.1038/1727. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES